Study Stopped
Corona
Effects of WiFi Exposure on Sleep in Women
1 other identifier
interventional
34
1 country
1
Brief Summary
Effects of Wifi exposure on sleep and sleep-related memory consolidation are investigated in a double-blind, sham-controlled fully counterbalanced study design in young healthy women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 24, 2020
CompletedFirst Posted
Study publicly available on registry
October 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFebruary 20, 2024
February 1, 2024
4.6 years
September 24, 2020
February 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Sleep Efficiency index
(total Sleep time in % of time in bed)
8 hours
Secondary Outcomes (2)
declarative memory
8 hours
Sleep EEG power
8 hours
Study Arms (2)
Experimental: WiFi - Sham
EXPERIMENTALfirst intervention WiFi, second intervention sham
Experimental: Sham - WiFi
EXPERIMENTALfirst Intervention sham, second Intervention WiFi
Interventions
Exposure system delivers emissions comparable to those from a WiFi access Point close to the bed or sham (no exposure)
Eligibility Criteria
You may qualify if:
- Only right-handed
- non-smokers
- Pittsburgh Sleep Quality Index (PSQI) score \< 5
- no extreme morning/evening preference \[Morningness-Eveningness Questionnaire (MEQ) score ≥ 31 or ≤ 69
- no indication of depression or somatic symptoms as assessed by a medical examination and validated questionnaires \[Patient Health Questionnaires (PHQ-9 and PHQ-15) scores ≤ 5 and ≤ 10, respectively
You may not qualify if:
- history of a psychiatric disorder,
- history of a neurological and/or sleep disorder
- excessive daytime sleepiness \[Epworth Sleepiness Scale (ESS) score \> 9;
- non-regular sleep-wake schedule as assessed by a sleep diary
- a regular intake of medication that affects the central nervous system, excessive caffeine and/or alcohol consumption, regular and occasional drug use,
- metal implants
- periodic leg movement arousal index \> 10/h in the Adaptation night
- apnoea-hypopnoea-index \> 5/h in the Adaptation night.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charite University, Berlin, Germanylead
- Seibersdorf Labor GmbHcollaborator
Study Sites (1)
Charité - University Medicine Berlin
Berlin, 12203, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Competence Center for Sleep Medicine
Study Record Dates
First Submitted
September 24, 2020
First Posted
October 12, 2020
Study Start
February 1, 2020
Primary Completion
September 1, 2024
Study Completion
December 1, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share